Showing results (121-130 of 125) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
The British Journal of Surgery|July 19, 2023
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastasesRuben A G van Eerden, Nadine L de Boer, Job P van Kooten, et al.European Journal of Cancer (Oxford, England : 1990)|January 8, 2022
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patientsEmma C Hulshof, Mirjam de With, Femke M de Man, et al.BMJ Open|January 18, 2024
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trialVincent C J van de Vlasakker, Niels A D Guchelaar, Teun B M van den Heuvel, et al.Clinical Pharmacokinetics|July 16, 2024
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma CohortMarinda Meertens, Eline L Giraud, Maud B A van der Kleij, et al.British Journal of Cancer|July 6, 2024
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective studyMaud B A van der Kleij, Niels A D Guchelaar, Marinda Meertens, et al.Pageof 13